Log in
Enquire now
‌

US Patent 12083181 Bi-functional molecules to degrade circulating proteins

Patent 12083181 was granted and assigned to Yale University on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Yale University
Yale University
0
Current Assignee
Yale University
Yale University
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120831810
Patent Inventor Names
David Spiegel0
David Caianiello0
Date of Patent
September 10, 2024
0
Patent Application Number
181616330
Date Filed
January 30, 2023
0
Patent Citations
‌
US Patent 10633375 Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
0
‌
US Patent 10703823 Chimeric small molecules for the recruitment of antibodies to cancer cells
0
‌
US Patent 11014992 Chimeric small molecules for the recruitment of antibodies to cancer cells
0
‌
US Patent 10912836 Synthetic antibody mimetic compounds (SyAMs) targeting cancer, especially prostate cancer
0
‌
US Patent 9181224 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
0
‌
US Patent 9296708 Chimeric small molecules for the recruitment of antibodies to cancer cells
0
‌
US Patent 9556167 TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
0
‌
US Patent 10016412 TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
0
...
Patent Primary Examiner
‌
Jeffrey S Lundgren
0
Patent abstract

Described herein is a bi-functional compound for removing macrophage migration inhibitory factor (MIF) or immunoglobulin G (IgG). Further described herein is a pharmaceutical composition which comprise these bi-functional compounds. Further described herein is a method for treating disease states and/or conditions with the compounds or the composition. The disease states and/or conditions are mediated through MIF/IgG or where MIF/IgG is a contributing factor to the development and perpetuation of diseases and/or conditions, such as autoimmune diseases and cancer, among others.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12083181 Bi-functional molecules to degrade circulating proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.